Clinically significant cardiac disease (New York Heart Association Class III/IV),or severe debilitating puhnonary disease. 
Uncontrolled serious active infection. 
Anticipated survival of less than 3 months. 
Active CNS or epiduraltumor 
Inability or unwillingness to comply with the treatment protocol, follow-up, or research tests.       
    
